Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease
References
- Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012; 379: 953–964. DOI: 10.1016/S0140-6736(11)61171-9
- Naghavi M, Wang HD, Lozano R, Davis A, Liang XF, Zhou MG, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385: 117–171. DOI: 10.1016/S0140-6736(14)61682-2
- Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology, and natural history of acquired mitral valve stenosis. Eur Heart J. 1991; 12(Suppl B): 55–60. DOI: 10.1093/eurheartj/12.suppl_B.55
- Leon MN, Harrell LC, Simosa HF, et al. Mitral balloon valvotomy for patients with mitral stenosis in atrial fibrillation: Immediate and long-term results. J Am Coll Cardiol. 1999; 34: 1145–52. DOI: 10.1016/S0735-1097(99)00310-1
- Nair KK, Pillai HS, Thajudeen A, et al. Immediate and long-term results following balloon mitral valvotomy in patients with atrial fibrillation. Clin Cardiol. 2012; 35: E35–9. DOI: 10.1002/clc.22068
- Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994; 90: 830–837. DOI: 10.1161/01.CIR.90.2.830
- Alexiou C, Doukas G, et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothorac Surg. 2007; 31: 586–591. DOI: 10.1016/j.ejcts.2006.12.039
- Kim HJ, Cho GY, Kim YJ, Kim HK, Lee SP, Kim HL, et al. Development of atrial fibrillation in patients with rheumatic mitral valve disease in sinus rhythm. Int J Cardiovasc Imaging. 2015; 31: 735–742. DOI: 10.1007/s10554-015-0613-2
- Ozaydin M, Turker Y, Varol E, Alaca S, Erdogan D, Yilmaz N, et al. Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis. Int J Cardiovasc Imaging. 2010; 26(5): 547–552. DOI: 10.1007/s10554-010-9609-0
- Pourafkari L, Ghaffari S, Bancroft GR, Tajlil A, Nader ND. Factors associated with atrial fibrillation in rheumatic mitral stenosis. Asian Cardiovasc Thorac Ann. 2015; 23(1): 17–23. DOI: 10.1177/0218492314530134
- Munn Z, Moola S, Lisy K, et al. Systematic reviews of prevalence and incidence. In Aromataris E & Munn Z (Eds.) Joanna Briggs Institute reviewer’s manual. Adelaide, South Australia: The Joanna Briggs Institute; 2017; 5.1–5.5.11.
- Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15): 2008–2012. DOI: 10.1001/jama.283.15.2008
- McGowan J, Sampson M, Salzwedel DM, et al. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016; 75: 40–6. DOI: 10.1016/j.jclinepi.2016.01.021
- Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare. 2015; 13: 147–53. DOI: 10.1097/XEB.0000000000000054
- Barendregt JJ, Doi SA, Lee YY, et al. Meta-analysis of prevalence. J Epidemiol Community Health. 2013; 67: 974–8. DOI: 10.1136/jech-2013-203104
- Cochran WG. The combination of estimates from different experiments. Biometrics. 1954; 10: 101–29. DOI: 10.2307/3001666
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002; 21: 1539–58. DOI: 10.1002/sim.1186
- Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315: 629–34. DOI: 10.1136/bmj.315.7109.629
- Seagroatt V, Stratton I. Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. BMJ (Clinical research ed). 1998; 316: 470–1.
- DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemporary Clinical Trials. 2015; 45: 139–45. DOI: 10.1016/j.cct.2015.09.002
- Abbas S, Riaz W, Khan JF, Nassery S, Iqbal M, Waheed A. Amiodarone vs digoxin in the treatment of atrial fibrillation in postoperative rheumatic cardiac valvular patients. J Pak Med Assoc. 2016; 66(9):1098–1101.
- De Santo LS, Romano G, Della Corte A, Tizzano F, Petraio A, Amarelli C, et al. Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3,707-patient-year follow-up. J Thorac Cardiovasc Surg. 2005; 130(1): 13–9. DOI: 10.1016/j.jtcvs.2004.11.032
- Lin SL, Hsu TL, Liou JY, Chen CH, Chang MS, Chiang HT, et al. Usefulness of transesophageal echocardiography for the detection of left atrial thrombi in patients with rheumatic heart disease. Echocardiography. Mar 1992; 9(2): 161–8. DOI: 10.1111/j.1540-8175.1992.tb00454.x
- Ozkan M, Kaymaz C, Kirma C, Civelek A, Cenal AR, Yakut C, et al. Correlates of left atrial thrombus and spontaneous echo contrast in rheumatic valve disease before and after mitral valve replacement. Am J Cardiol. 1 Nov 1998; 82(9): 1066–70. DOI: 10.1016/S0002-9149(98)00556-6
- Chen CR, Cheng TO, Chen JY, Huang YG, Huang T, Zhang B. Long-term results of percutaneous balloon mitral valvuloplasty for mitral stenosis: A follow-up study to 11 years in 202 patients. Cathet Cardiovasc Diagn. Feb 1998; 43(2): 132–9. DOI: 10.1002/(SICI)1097-0304(199802)43:2<;132::AID-CCD5>3.0.CO;2-B
- Cruz-Gonzalez I, Jneid H, Sanchez-Ledesma M, Cubeddu RJ, Martin-Moreiras J, Rengifo-Moreno P, et al. Difference in outcome among women and men after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv. 1 Jan 2011; 77(1): 115–20. DOI: 10.1002/ccd.22721
- Esteves WAM, Lodi-Junqueira L, Soares JR, Sant’Anna Athayde GR, Goebel GA, Carvalho LA, et al. Impact of percutaneous mitral valvuloplasty on left ventricular function in patients with mitral stenosis assessed by 3D echocardiography. Int J Cardiol. 1 Dec 2017; 248: 280–5. DOI: 10.1016/j.ijcard.2017.06.078
- Kim D, Chung H, Nam J-H, Park DH, Shim CY, Kim J-S, et al. Correlates of long-term outcomes of percutaneous mitral valvuloplasty in patients with rheumatic mitral stenosis. Yonsei Med J. 1 Mar 2018; 59(2): 273–8. DOI: 10.3349/ymj.2018.59.2.273
- Lim E, Barlow CW, Hosseinpour AR, Wisbey C, Wilson K, Pidgeon W, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation. 18 Sep 2001; 104(12 Suppl 1): I59–63. DOI: 10.1161/hc37t1.094813
- Ostovan M, Aslani A, Abounajmi S, Razazi V. Mitral valve restenosis after percutaneous transmitral valvuloplasty, role of continuous inflammation. J Cardiovasc Thorac Res. 2014; 6(3): 191–5. DOI: 10.15171/jcvtr.2014.010
- Ranganayakulu KP, Rajasekhar D, Vanajakshamma V, Santosh Kumar C, Vasudeva Chetty P. N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy. J Saudi Heart Assoc. Apr 2016; 28(2): 81–8. DOI: 10.1016/j.jsha.2015.07.002
- Sancho M, Medina A, Suárez de Lezo J, Hernandez E, Pan M, Coello I, et al. Factors influencing progression of mitral regurgitation after transarterial balloon valvuloplasty for mitral stenosis. Am J Cardiol. 15 Sep 1990; 66(7): 737–40. DOI: 10.1016/0002-9149(90)91140-2
- Shang YP, Lai L, Chen J, Zhang F, Wang X. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation. J Heart Valve Dis. Jul 2005; 14(4): 453–9.
- Tomai F, Gaspardone A, Versaci F, Ghini AS, Altamura L, De Luca L, et al. Twenty-year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis. Int J Cardiol. 20 Dec 2014; 177(3): 881–5. DOI: 10.1016/j.ijcard.2014.10.040
- Guteta S, Yadeta D, Azazh A, Mekonnen D. Cardiac surgery for valvular heart disease at a referral hospital in ethiopia: A review of cases operated in the last 30 years. Ethiop Med J. Apr 2016; 54(2): 49–55.
- Russell EA, Tran L, Baker RA, Bennetts JS, Brown A, Reid CM, et al. A review of outcome following valve surgery for rheumatic heart disease in Australia. BMC Cardiovasc Disord. 23 Sep 2015; 15: 103. DOI: 10.1186/s12872-015-0094-1
- Adhikari CM, Malla R, Rajbhandari R, Shakya U, Sharma P, Shrestha N, et al. Percutaneous transvenous mitral commissurotomy in juvenile mitral stenosis. Cardiovasc Diagn Ther. Feb 2016; 6(1): 20–4.
- Augestad KM, Martyshova K, Martyshov S, Foederov B, Lie M. Tidsskr Den Nor Laegeforening Tidsskr Prakt Med Ny Raekke. [Rheumatic fever and rheumatic heart disease in Northwest Russia]. 20 Apr 1999; 119(10): 1456–9.
- Bouleti C, Iung B, Himbert D, Messika-Zeitoun D, Brochet E, Garbarz E, et al. Relationship between valve calcification and long-term results of percutaneous mitral commissurotomy for rheumatic mitral stenosis. Circ Cardiovasc Interv. Jun 2014; 7(3): 381–9. DOI: 10.1161/CIRCINTERVENTIONS.113.000858
- Hernández Antolín RA, Macaya de Miguel C, Bañuelos de Lucas C, Alfonso Manterola F, Goicolea Ruigómez J, Iñíguez Romo A, et al. [Percutaneous mitral valvotomy. The experience of the Hospital Universitario San Carlos of Madrid]. Rev Esp Cardiol. Jun1993; 46(6): 352–63.
- Mahmoud Elsayed HM, Hassan M, Nagy M, Amin A, Elguindy A, Wagdy K, et al. A novel method to measure mitral valve area in patients with rheumatic mitral stenosis using three-dimensional transesophageal echocardiography: Feasibility and validation. Echocardiogr Mt Kisco N. 2018; 35(3): 368–74. DOI: 10.1111/echo.13786
- Malik A, Khan RA, Ali Shah SM, Awan AA, Aslam S, Rehman K. Should we say good bye to closed mitral commissurotomy in our setup. J Postgrad Med Inst. Apr 2005; 19(2): 144–8.
- Rajbhandari R, Kc MB, Bhatta Y, Regmi S, Malla R, Rajbhandari S, et al. Percutaneous transvenous mitral commissurotomy. Nepal Med Coll J NMCJ. Sep 2006; 8(3): 182–4.
- Sharma J, Goel PK, Pandey CM, Awasthi A, Kapoor A, Tewari S, et al. Intermediate outcomes of rheumatic mitral stenosis post-balloon mitral valvotomy. Asian Cardiovasc Thorac Ann. Oct 2015; 23(8): 923–30. DOI: 10.1177/0218492315598240
- Souza LR, Brandão CM de A, Pomerantzeff PMA, Leite Filho OA, Cardoso LF, Stolf NAG. Long-term evolution of mitral commissurotomy in rheumatic patients with low echocardiographic score. Rev Bras Cir Cardiovasc Orgao Of Soc Bras Cir Cardiovasc. Sep 2011; 26(3): 380–5. DOI: 10.5935/1678-9741.20110012
- Srimahachota S, Boonyaratavej S, Wannakrairoj M, Udayachalerm W, Sangwattanaroj S, Ngarmukos P, et al. Percutaneous transvenous mitral commissurotomy: Hemodynamic and initial outcome differences between atrial fibrillation and sinus rhythm in rheumatic mitral stenosis patients. J Med Assoc Thai. May 2001; 84(5): 674–80.
- Choudhary SK, Dhareshwar J, Govil A, Airan B, Kumar AS. Open mitral commissurotomy in the current era: Indications, technique, and results. Ann Thorac Surg. Jan 2003; 75(1): 41–6. DOI: 10.1016/S0003-4975(02)04276-5
- Luo T, Han J, Meng X. Features of rheumatic mitral valves and a grading system to identify suitable repair cases in China. J Thorac Dis. Sep 2017; 9(9): 3138–47. DOI: 10.21037/jtd.2017.08.121
- Russell EA, Walsh WF, Tran L, Tam R, Reid CM, Brown A, et al. The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients. Int J Cardiol. 15 Jan 2017; 227: 100–5. DOI: 10.1016/j.ijcard.2016.11.070
- Sarralde JA, Bernal JM, Llorca J, Pontón A, Diez-Solorzano L, Giménez-Rico JR, et al. Repair of rheumatic tricuspid valve disease: Correlates of very long-term mortality and reoperation. Ann Thorac Surg. Aug 2010; 90(2): 503–8. DOI: 10.1016/j.athoracsur.2010.03.105
- Acartürk E, Usal A, Demir M, Akgül F, Ozeren A. Thromboembolism risk in patients with mitral stenosis. Jpn Heart J. Sep 1997; 38(5): 669–75. DOI: 10.1536/ihj.38.669
- Adhikari KP, Malla R, Limbu D, Rauniyar BK, Regmi S, Hirachan A, et al. Prevalence of atrial fibrillation in patients attending emergency department of Shahid Gangalal National Heart Centre, Kathmandu, Nepal. Nepal Heart J. 12 Feb 2016; 13(1): 1–4. DOI: 10.3126/njh.v13i1.14536
- Arora R, Kalra GS, Murty GS, Trehan V, Jolly N, Mohan JC, et al. Percutaneous transatrial mitral commissurotomy: Immediate and intermediate results. J Am Coll Cardiol. May 1994; 23(6): 1327–32. DOI: 10.1016/0735-1097(94)90374-3
- Behra SS, Anil Kumar AVS, Singh H, Satyanand K. To study the prevalence of arrhythmias in valvular heart disease and their correlation with echocardiographic variables. J Clin Diagn Res. Nov 2018; 12(11): 12–9.
- Boonyasirinant T, Phankinthongkum R, Komoltri C. Clinical and echocardiographic parameters and score for the left atrial thrombus formation prediction in the patients with mitral stenosis. J Med Assoc Thail Chotmaihet Thangphaet. Nov 2007; 90 (suppl 2): 9–18.
- Boyarchuk O, Hariyan T, Kovalchuk T. Clinical features of rheumatic heart disease in children and adults in Western Ukraine. Bangladesh J Med Sci. 2019; 18(1): 87–93. DOI: 10.3329/bjms.v18i1.39556
- Chockalingam A, Gnanavelu G, Elangovan S, Chockalingam V. Clinical spectrum of chronic rheumatic heart disease in India. J Heart Valve Dis. Sep 2003; 12(5): 577–81.
- Chu PH, Chiang CW, Hsu LA, Lin KH, Cheng NJ, Kuo CT. Low prevalence of coronary arterial disease in Chinese adults with mitral stenosis. Chang Gung Med J. Feb 2001; 24(2): 97–102.
- Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, et al. Prevalence and correlates of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 1 Jan 1996; 77(1): 96–8. DOI: 10.1016/S0002-9149(97)89145-X
- Doukky R, Abusin SA, Bayissa YA, Kelly RF, Ansari AH. Rheumatic heart disease in modern urban America: A cohort study of immigrant and indigenous patients in Chicago. Int J Cardiol. 15 Jul 2014; 175(1): 178–80. DOI: 10.1016/j.ijcard.2014.04.207
- Drighil A, Ghellab D, Mathewson JW, Ouarga L, Alalou H, Azzouzi L. Immediate impact of successful percutaneous mitral valve commissurotomy on echocardiographic measures of right ventricular contractility. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. Nov 2012; 25(11): 1245–50. DOI: 10.1016/j.echo.2012.08.010
- Fawzy ME, Shoukri M, Fadel B, Badr A, Al Ghamdi A, Canver C. Long-term (up to 18 years) clinical and echocardiographic results of mitral balloon valvuloplasty in 531 consecutive patients and correlates of outcome. Cardiology. 2009; 113(3): 213–21. DOI: 10.1159/000201992
- Gamra H, Betbout F, Ben Hamda K, Addad F, Maatouk F, Dridi Z, et al. Balloon mitral commissurotomy in juvenile rheumatic mitral stenosis: A ten-year clinical and echocardiographic actuarial results. Eur Heart J. Jul 2003; 24(14): 1349–56. DOI: 10.1016/S0195-668X(03)00257-4
- Goswami KC, Yadav R, Bahl VK. Correlates of left atrial appendage clot: A transesophageal echocardiographic study of left atrial appendage function in patients with severe mitral stenosis. Indian Heart J. Dec 2004; 56(6): 628–35.
- Goswami KC, Yadav R, Rao MB, Bahl VK, Talwar KK, Manchanda SC. Clinical and echocardiographic correlates of left atrial clot and spontaneous echo contrast in patients with severe rheumatic mitral stenosis: A prospective study in 200 patients by transesophageal echocardiography. Int J Cardiol. 31 May 2000; 73(3): 273–9. DOI: 10.1016/S0167-5273(00)00235-7
- Hung JS, Chern MS, Wu JJ, Fu M, Yeh KH, Wu YC, et al. Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy. Am J Cardiol. 15 Apr 1991; 67(9): 854–62. DOI: 10.1016/0002-9149(91)90619-V
- Islam A, Azhar MA, Islam MF, Haque MZ, Yeasmin L. A clinical study on the pattern of mitral valvular disease in a peripheral tertiary hospital in Bangladesh. Cardiovasc J. 2010; 3(1): 11–21. DOI: 10.3329/cardio.v3i1.6421
- López-Meneses M, Martínez Ríos MA, Vargas Barrón J, Reyes Corona J, Sánchez F. Ten-year clinical and echocardiographic follow-up of patients undergoing percutaneous mitral commissurotomy with Inoue balloon. Arch Cardiol Mex. Mar 2009; 79(1): 5–10.
- Iung B, Nicoud-Houel A, Fondard O, Hafid Akoudad null, Haghighat T, Brochet E, et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J. Apr 2004; 25(8): 701–7. DOI: 10.1016/j.ehj.2004.02.026
- Melka A. Rheumatic heart disease in Gondar College of Medial Sciences Teaching Hospital: Socio-demographic and clinical profile. Ethiop Med J. Oct 1996; 34(4): 207–16.
- Mrozowska E, Krzemińska-Pakuła M, Rogowski W, Musiał WJ, Zasłonka J. [Atrial fibrillation in mitral valve disease—Risk factors]. Pol Arch Med Wewn. Jan 1999; 101(1): 45–53.
- Negi PC, Mahajan K, Rana V, Sondhi S, Mahajan N, Rathour S, et al. Clinical characteristics, complications, and treatment practices in patients with RHD: 6-year results from HP-RHD registry. Glob Heart. 2018; 13(4): 267–274.e2. DOI: 10.1016/j.gheart.2018.06.001
- Okello E, Wanzhu Z, Musoke C, Twalib A, Kakande B, Lwabi P, et al. Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda. Cardiovasc J Afr. Apr 2013; 24(3): 80–5. DOI: 10.1186/s12872-016-0451-8
- Okello E, Longenecker CT, Beaton A, Kamya MR, Lwabi P. Rheumatic heart disease in Uganda: Correlates of morbidity and mortality one year after presentation. BMC Cardiovasc Disord. 2017; 17(1): 20.
- Okubo S, Nagata S, Masuda Y, Kawazoe K, Atobe M, Manabe H. Clinical features of rheumatic heart disease in Bangladesh. Jpn Circ J. Dec 1984; 48(12): 1345–9. DOI: 10.1253/jcj.48.1345
- Pourafkari L, Baghbani-Oskouei A, Aslanabadi N, Tajlil A, Ghaffari S, Sadigh AM, et al. Fine versus coarse atrial fibrillation in rheumatic mitral stenosis: The impact of aging and the clinical significance. Ann Noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiol Inc. 2018; 23(4):
e12540 . DOI: 10.1111/anec.12540 - Sharma SK, Verma SH. A clinical evaluation of atrial fibrillation in rheumatic heart disease. J Assoc Physicians India. Jun 2015; 63(6): 22–5.
- Shimada S. A 13-year follow-up study of rheumatic valvular diseases. Jpn Circ J. Dec 1986; 50(12): 1304–8. DOI: 10.1253/jcj.50.1304
- Sims JB, Roberts WC. Comparison of findings in patients with versus without atrial fibrillation just before isolated mitral valve replacement for rheumatic mitral stenosis (with or without associated mitral regurgitation). Am J Cardiol. 1 Apr 2006; 97(7): 1035–8. DOI: 10.1016/j.amjcard.2005.11.023
- Sliwa K, Mocumbi AO. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol Off J Ger Card Soc. Feb 2010; 99(2): 65–74. DOI: 10.1007/s00392-009-0094-1
- Tadele H, Mekonnen W, Tefera E. Rheumatic mitral stenosis in children: More accelerated course in sub-Saharan patients. BMC Cardiovasc Disord. 1 Nov 2013; 13: 95. DOI: 10.1186/1471-2261-13-95
- Vijayvergiya R, Sharma R, Shetty R, Subramaniyan A, Karna S, Chongtham D. Effect of percutaneous transvenous mitral commissurotomy on left atrial appendage function: An immediate and 6-month follow-up transesophageal Doppler study. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. Nov 2011; 24(11): 1260–7. DOI: 10.1016/j.echo.2011.07.015
- Yadeta D, Semeredin N, Mekonnen GE. Prevalence and correlates of atrial fibrillation and its embolic complications in patients with rheumatic heart disease at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop J Health Dev. 2019; 33(1): 12–16.
- Zhang W, Mondo C, Okello E, Musoke C, Kakande B, Nyakoojo W, et al. Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: A pilot study. Cardiovasc J Afr. Mar 2013; 24(2): 28–33. DOI: 10.5830/CVJA-2012-076
- Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol. 2008; 18(5): 209–16. DOI: 10.2188/jea.JE2008021
- Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical outcomes in 3,343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: Two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 8 Nov 2016; 134(19): 1456–1466.
- Buyukkaya S, Buyukkaya E, Arslan S, Aksakal E, Sevimli S, Gundogdu F, et al. Evaluation of left ventricular long-axis function in cases of rheumatic pure mitral stenosis with atrial fibrillation. Tex Heart Inst J. 2008; 35(1): 22–7.
- Kabukçu M, Arslantas E, Ates I, Demircioglu F, Ersel F. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation. Angiology. Mar–Apr 2005; 56(2): 159–63. DOI: 10.1177/000331970505600206
- Ancona R, Comenale Pinto S, Caso P, Di Salvo G, Severino S, D’Andrea A, et al. Two-dimensional atrial systolic strain imaging predicts atrial fibrillation at 4-year follow-up in asymptomatic rheumatic mitral stenosis. J Am Soc Echocardiogr. Mar 2013; 26(3): 270–7. DOI: 10.1016/j.echo.2012.11.016
- Keren G, Etzion T, Sherez J, Zelcer AA, Megidish R, Miller HI, et al. Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J. Nov 1987; 114(5): 1146–55. DOI: 10.1016/0002-8703(87)90190-6
- Krishnamoorthy KM, Dash PK. Prediction of atrial fibrillation in patients with severe mitral stenosis—Role of atrial contribution to ventricular filling. Scand Cardiovasc J. Dec 2003; 37(6): 344–8. DOI: 10.1080/14017430310015893
- Sabry AM, Mansour HAE, Abo El-Azm TH, Mostafa SA, Zahid BS. Echocardiographic correlates of atrial fibrillation after mitral valve replacement. Egypt Heart J. Dec 2017; 69(4): 281–288. DOI: 10.1016/j.ehj.2017.07.002
- Sharma G, Shetkar S, Bhasin A, Ramakrishnan L, Juneja R, Naik N, et al. High sensitive C-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort. Indian Heart J. Jul–Aug 2017; 69(4): 505–511. DOI: 10.1016/j.ihj.2016.12.006
- Probst P, Goldschlager N, Selzer A. Left atrial size and atrial fibrillation in mitral stenosis. Factors influencing their relationship. Circulation. Dec 1973; 48(6): 1282–7. DOI: 10.1161/01.CIR.48.6.1282
- Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. Feb 1976; 53(2): 273–9. DOI: 10.1161/01.CIR.53.2.273
- Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: Determinants and long-term outcome. J Am Coll Cardiol. 3 Jul 2002; 40(1): 84–92. DOI: 10.1016/S0735-1097(02)01922-8
- Selcuk MT, Selcuk H, Maden O, Temizhan A, Aksu T, Dogan M, et al. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis. J Heart Valve Dis. Sep 2007; 16(5): 468–74.
- Alessandri N, Tufano F, Petrassi M, Alessandri C, Di Cristofano C, Della Rocca C, et al. Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change. Eur Rev Med Pharmacol Sci. Nov–Dec 2009; 13(6): 431–42.
- Duran NE, Duran I, Sönmez K, Gençbay M, Akçay A, Turan F. Frequency and correlates of atrial fibrillation in severe mitral regurgitation. Anadolu Kardiyol Derg. Jun 2003; 3(2): 129–34.
- Khatouri A, Elyounassi B, Kendoussi M, Moyoupa C, Fall PD, Bahji M, et al. Predictive factors of atrial fibrillation in mitral stenosis. Clinical and echocardiographic study. Ann Cardiol Angeiol (Paris). Oct 1999; 48(8): 569–73.
- Unverferth DV, Fertel RH, Unverferth BJ, Leier CV. Atrial fibrillation in mitral stenosis: Histologic, hemodynamic, and metabolic factors. Int J Cardiol. Feb 1984; 5(2): 143–54. DOI: 10.1016/0167-5273(84)90137-2
- Noubiap JJ, Bigna JJ, Agbor VN, Mbanga C, Ndoadoumgue AL, Nkeck JR, et al. Meta-analysis of atrial fibrillation in patients with various cardiomyopathies. Am J Cardiol. 15 Jul 2019; 124(2): 262–269. DOI: 10.1016/j.amjcard.2019.04.028
- Stambler BS, Ngunga LM. Atrial fibrillation in Sub-Saharan Africa: Epidemiology, unmet needs, and treatment options. Int J Gen Med. 31 Jul 2015; 8: 231–42. DOI: 10.2147/IJGM.S84537
- Bonny A, Ngantcha M, Sholtz W, Chin A, Nel G, Anzouan-Kacou JB, et al. Cardiac arrhythmias in Africa: Epidemiology, management challenges, and perspectives. J Am Coll Cardiol. 2019; 73(1): 100–109. DOI: 10.1016/j.jacc.2018.09.084
- Lip GY, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, et al. Atrial fibrillation. Nat Rev Dis Primers. 2016; 2: 16016. DOI: 10.1038/nrdp.2016.16
- Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 16 Dec 2003; 108(24): 3006–10. DOI: 10.1161/01.CIR.0000103131.70301.4F
- Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Int J Cardiol. 10 May 2006; 109(2): 275–6. DOI: 10.1016/j.ijcard.2005.04.030
- Gölbasi Z, Uçar O, Keles T, Sahin A, Cagli K, Camsari A, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: Evidence of ongoing inflammation. Eur J Heart Fail. Oct 2002; 4(5): 593–5. DOI: 10.1016/S1388-9842(02)00102-2
- Yetkin E, Erbay AR, Ileri M, Turhan H, Balci M, Cehreli S, et al. Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol. 15 Nov 2001; 88(10): 1209–11. DOI: 10.1016/S0002-9149(01)02067-7
- Dakay K, Chang AD, Hemendinger M, Cutting S, McTaggart RA, Jayaraman MV, et al. Left atrial enlargement and anticoagulation status in patients with acute ischemic stroke and atrial fibrillation. J Stroke Cerebrovasc Dis. Jan 2018; 27(1): 192–197. DOI: 10.1016/j.jstrokecerebrovasdis.2017.08.025
- Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation. 12 May 2009; 119(18): 2516–25. DOI: 10.1161/CIRCULATIONAHA.108.821306
- Van Gelder IC, Crijns HJ, Tieleman RG. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996; 156(22): 2585–92. DOI: 10.1001/archinte.1996.00440210109011
- Grigioni F, Benfari G, Vanoverschelde JL, Tribouilloy C, Avierinos JF, Bursi F, et al. Long-term implications of atrial fibrillation in patients with degenerative mitral regurgitation. J Am Coll Cardiol. 29 Jan 2019; 73(3): 264–274.
- Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: The RE-LY Atrial Fibrillation Registry. Circulation. 15 Apr 2014; 129(15): 1568–76. DOI: 10.1161/CIRCULATIONAHA.113.005451
DOI: https://doi.org/10.5334/gh.807 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 16, 2020
Accepted on: Apr 16, 2020
Published on: May 18, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Jean Jacques Noubiap, Ulrich Flore Nyaga, Aude Laetitia Ndoadoumgue, Jan René Nkeck, Anderson Ngouo, Jean Joel Bigna, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.